NCT06807983 LUng and Cardiac Ultrasound for REspiratory Distress in ElDerly
| NCT ID | NCT06807983 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Toulouse |
| Condition | Dyspnea |
| Study Type | INTERVENTIONAL |
| Enrollment | 504 participants |
| Start Date | 2025-11-04 |
| Primary Completion | 2027-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 504 participants in total. It began in 2025-11-04 with a primary completion date of 2027-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective trial to evaluate the impact on the initial therapeutic inadequacy of a management strategy for acute dyspnea in the elderly based on the use of lung and cardiac ultrasonography.
Eligibility Criteria
Inclusion Criteria: Eligible patients will be aged over 65 years, affiliated with the French social security system, and presenting to the ED with acute dyspnea (onset \<14 days) accompanied by severity signs before or at triage (respiratory rate ≥22 and SpO2 \<92% on room air). The enrolling emergency physician (EP) must be the patient's treating physician and must be trained in LuCUS. Written informed consent from the patient or their legal representative is required for inclusion Exclusion Criteria: dyspnea secondary to thoracic trauma, dyspnea clearly related to COVID-19, known pulmonary fibrosis or lung cancer, prior administration of specific treatment for dyspnea before inclusion, immediate need for endotracheal intubation, patients identified as being at end-of-life, and individuals under legal guardianship or deprived of liberty.
Contact & Investigator
Frédéric BALEN, MD
PRINCIPAL INVESTIGATOR
University Hospital, Toulouse
Frequently Asked Questions
Who can join the NCT06807983 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Dyspnea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06807983 currently recruiting?
Yes, NCT06807983 is actively recruiting participants. Contact the research team at hebrard.m@chu-toulouse.fr for enrollment information.
Where is the NCT06807983 trial being conducted?
This trial is being conducted at Toulouse, France.
Who is sponsoring the NCT06807983 clinical trial?
NCT06807983 is sponsored by University Hospital, Toulouse. The principal investigator is Frédéric BALEN, MD at University Hospital, Toulouse. The trial plans to enroll 504 participants.